PT Millennium Pharmacon International Tbk(ID:SDPC)
Rp186.00+6.00 (+1.64%)
ID:SDPC
PT Millennium Pharmacon International Tbk financials statements
Rp186.00
At close:+6.00 (+1.64%)
PT Millennium Pharmacon International Tbk (SDPC) Ratios
PT Millennium Pharmacon International Tbk Ratios
ID:SDPC's free cash flow for Q2 2026 was Rp-102.38B. For the 2026 fiscal year, ID:SDPC's free cash flow was decreased by Rp-992.03M and operating cash flow was Rp-101.39B. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Mar 23 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.10 | 1.11 | 1.12 | 1.13 | 1.14 |
| Quick Ratio | 0.71 | 0.70 | 0.71 | 0.65 | 0.65 |
| Cash Ratio | 0.04 | 0.04 | 0.05 | 0.02 | 0.05 |
| Solvency Ratio | 0.04 | 0.03 | 0.04 | 0.04 | 0.03 |
| Operating Cash Flow Ratio | 0.06 | -0.09 | -0.07 | 0.04 | -0.02 |
| Short-Term Operating Cash Flow Coverage | 0.12 | -0.16 | -0.14 | 0.07 | -0.04 |
| Net Current Asset Value | Rp 73.63B | Rp 74.43B | Rp 85.68B | Rp 116.36B | Rp 100.90B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.41 | 0.48 | 0.43 | 0.41 | 0.38 |
| Debt-to-Equity Ratio | 2.57 | 3.00 | 2.56 | 2.19 | 1.93 |
| Debt-to-Capital Ratio | 0.72 | 0.75 | 0.72 | 0.69 | 0.66 |
| Long-Term Debt-to-Capital Ratio | 0.14 | 0.13 | 0.14 | 0.00 | 0.00 |
| Financial Leverage Ratio | 6.22 | 6.27 | 5.90 | 5.41 | 5.09 |
| Debt Service Coverage Ratio | 0.17 | 0.13 | 0.15 | 0.12 | 0.12 |
| Interest Coverage Ratio | 2.00 | 1.40 | 1.83 | 1.92 | 1.45 |
| Debt to Market Cap | 4.10 | 5.03 | 3.57 | 1.47 | 2.97 |
| Interest Debt Per Share | 686.20 | 718.46 | 602.76 | 476.09 | 389.99 |
| Net Debt to EBITDA | 4.88 | 6.61 | 5.23 | 5.93 | 5.56 |
| Profitability Margins | |||||
| Gross Profit Margin | 8.25% | 8.54% | 8.62% | 8.42% | 8.09% |
| EBIT Margin | 3.15% | 2.46% | 3.14% | 2.34% | 1.93% |
| EBITDA Margin | 3.72% | 3.07% | 3.70% | 2.86% | 2.46% |
| Operating Profit Margin | 3.15% | 2.46% | 3.13% | 2.31% | 1.93% |
| Pretax Profit Margin | 1.19% | 0.71% | 1.43% | 1.14% | 0.60% |
| Net Profit Margin | 0.94% | 0.43% | 0.98% | 0.76% | 0.32% |
| Continuous Operations Profit Margin | 0.94% | 0.43% | 0.98% | 0.76% | 0.32% |
| Net Income Per EBT | 78.67% | 61.06% | 68.99% | 67.09% | 53.40% |
| EBT Per EBIT | 37.73% | 28.73% | 45.50% | 49.30% | 31.04% |
| Return on Assets (ROA) | 1.96% | 0.95% | 2.02% | 1.75% | 0.79% |
| Return on Equity (ROE) | 12.20% | 5.99% | 11.91% | 9.45% | 4.04% |
| Return on Capital Employed (ROCE) | 32.01% | 26.90% | 29.88% | 25.64% | 21.89% |
| Return on Invested Capital (ROIC) | 8.78% | 5.07% | 7.14% | 5.46% | 3.96% |
| Return on Tangible Assets | 1.97% | 0.96% | 2.03% | 1.76% | 0.80% |
| Earnings Yield | 19.48% | 10.06% | 16.65% | 5.78% | 5.52% |
| Efficiency Ratios | |||||
| Receivables Turnover | 4.93 | 5.28 | 4.93 | 5.63 | 6.48 |
| Payables Turnover | 5.43 | 6.79 | 5.63 | 6.26 | 6.65 |
| Inventory Turnover | 6.19 | 6.31 | 5.74 | 5.44 | 6.06 |
| Fixed Asset Turnover | 29.67 | 35.16 | 29.87 | 76.57 | 79.93 |
| Asset Turnover | 2.10 | 2.21 | 2.05 | 2.28 | 2.48 |
| Working Capital Turnover Ratio | 26.22 | 25.19 | 21.94 | 23.39 | 23.59 |
| Cash Conversion Cycle | 65.78 | 73.20 | 72.91 | 73.52 | 61.61 |
| Days of Sales Outstanding | 74.05 | 69.11 | 74.10 | 64.83 | 56.31 |
| Days of Inventory Outstanding | 58.96 | 57.84 | 63.63 | 67.05 | 60.23 |
| Days of Payables Outstanding | 67.22 | 53.75 | 64.82 | 58.35 | 54.93 |
| Operating Cycle | 133.00 | 126.95 | 137.73 | 131.87 | 116.54 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 69.15 | -98.47 | -71.94 | 32.18 | -14.27 |
| Free Cash Flow Per Share | 30.61 | -109.58 | -88.83 | 20.66 | -17.78 |
| Dividend Paid and CapEx Coverage Ratio | 1.71 | -7.23 | -3.81 | 2.57 | -3.56 |
| Capital Expenditure Coverage Ratio | 1.79 | -8.86 | -4.26 | 2.79 | -4.06 |
| Operating Cash Flow Coverage Ratio | 0.11 | -0.15 | -0.13 | 0.07 | -0.04 |
| Operating Cash Flow to Sales Ratio | 0.02 | -0.03 | -0.03 | 0.01 | -0.01 |
| Free Cash Flow Yield | 19.75% | -83.02% | -56.94% | 6.22% | -13.07% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 5.13 | 9.94 | 6.01 | 17.29 | 18.11 |
| Price-to-Sales (P/S) Ratio | 0.05 | 0.04 | 0.06 | 0.13 | 0.06 |
| Price-to-Book (P/B) Ratio | 0.63 | 0.60 | 0.72 | 1.63 | 0.73 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 5.06 | -1.20 | -1.76 | 16.07 | -7.65 |
| Price-to-Operating Cash Flow Ratio | 2.24 | -1.34 | -2.17 | 10.32 | -9.53 |
| Price-to-Earnings Growth (PEG) Ratio | 0.04 | -0.20 | 0.17 | 0.11 | 0.08 |
| Enterprise Value Multiple | 6.17 | 8.01 | 6.83 | 10.55 | 7.92 |
| Enterprise Value | 943.91B | 961.22B | 850.18B | 965.36B | 582.85B |
| EV to EBITDA | 6.17 | 8.01 | 6.83 | 10.55 | 7.92 |
| EV to Sales | 0.23 | 0.25 | 0.25 | 0.30 | 0.20 |
| EV to Free Cash Flow | 24.21 | -6.89 | -7.51 | 36.68 | -25.73 |
| EV to Operating Cash Flow | 10.71 | -7.66 | -9.28 | 23.55 | -32.07 |
| Tangible Book Value Per Share | 242.08 | 215.63 | 210.81 | 192.53 | 182.17 |
| Shareholders’ Equity Per Share | 247.59 | 221.75 | 217.99 | 203.23 | 186.01 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.21 | 0.39 | 0.31 | 0.33 | 0.47 |
| Revenue Per Share | 3225.91 | 3074.46 | 2640.12 | 2512.43 | 2346.03 |
| Net Income Per Share | 30.20 | 13.28 | 25.97 | 19.20 | 7.51 |
| Tax Burden | 0.79 | 0.61 | 0.69 | 0.67 | 0.53 |
| Interest Burden | 0.38 | 0.29 | 0.45 | 0.49 | 0.31 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.02 | 0.02 | 0.06 | 0.02 | 0.02 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 2.29 | -7.41 | -2.77 | 1.68 | -1.90 |
Currency in IDR
